source
- ReCode Therapeutics appoints Heather Clark as CEO to lead cystic fibrosis and primary ciliary dyskinesia programsReCode Therapeutics announced that Heather Clark will take over as chief executive officer, succeeding founder Shehnaaz Suliman. The transition was presented as a move to keep momentum after the co…
- Trump's Department of War bets $47M on Flagship biotechs to develop countermeasuresThe Department of War has awarded Flagship Pioneering $47 million to develop medical countermeasure technologies against emerging threats.